Reported about 10 hours ago
Moderna Inc. has been granted an additional $590 million by the US government to support the development of a vaccine against bird flu, specifically the H5N1 strain. This funding will aid in late-stage vaccine development and expand human studies for new influenza subtypes. The ongoing bird flu outbreak has raised concerns among public health officials, and as Moderna prepares to advance its vaccine into late-stage studies, it aims to provide results from its early trials at an upcoming scientific meeting.
Source: YAHOO